MedPath

Daily Bitemporal Low-frequency Transcranial Random Noise Stimulation in Tinnitus (tRNS2-tin)

Not Applicable
Recruiting
Conditions
Chronic Tinnitus
Interventions
Device: lf-tRNS
Registration Number
NCT02615600
Lead Sponsor
University of Regensburg
Brief Summary

Stimulation of the left and right auditory cortex with daily low-frequency transcranial random noise stimulation (tRNS) is used to modulate the neural pathways involved in chronic tinnitus.

Detailed Description

Tinnitus is the phantom auditory perception of sound in the absence of an external or internal acoustic stimulus. It is a frequent problem which can interfere significantly with the ability to lead a normal life. Tinnitus has been shown to be generated in the brain, as a result of functional reorganization of auditory neural pathways and the central auditory system. These changes are represented by hyper-activity and hyper-synchronicity in the auditory pathway. Treatment remains difficult. Non-invasive brain stimulation methods has shown to be effective in the treatment of chronic tinnitus with moderate effect size. First data suggest the use of transcranial random noise stimulation (tRNS) over both auditory cortices as new and highly effective treatment. Low-frequency (lf; \<100Hz) tRNS might be highly effective in tackling hyper-synchronised cell assemblies. Daily lf-tRNS (2 weeks) will be examined with regard to feasibility, safety and clinical efficacy in patients suffering from chronic tinnitus in an one-arm pilot trial.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
lf-tRNSlf-tRNSLow-frequency tRNS (Neuroconn, Eldith DC-Stimulator Plus): \<100Hz, 2mA, 20min, 10s ramp time, left and right auditory cortex, 5x7cm electrode with the inferior middle part over T3/T4
Primary Outcome Measures
NameTimeMethod
number of treatment respondersweek 12

response: tinnitus questionnaire total score reduction of at least 5 points, contrast baseline versus end of treatment (week 12)

Secondary Outcome Measures
NameTimeMethod
change in tinnitus questionnaireweek 2, week 4, week 12

change in tinnitus questionnaire

change in tinnitus numeric rating scalesweek 2, week 4, week 12

change in tinnitus numeric rating scales

change in tinnitus handicap inventoryweek 2, week 4, week 12

change in tinnitus handicap inventory

Trial Locations

Locations (1)

University of Regensburg - Deptartment of Psychiatry

🇩🇪

Regensburg, Germany

© Copyright 2025. All Rights Reserved by MedPath